| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  IDS Group SAS IDS-Inside; if you want to know the truth IDS Group SAS is a deep tech company with patented technology using isotopes for traceability and marking technologies across industries where source of origin, traceability and authenticity are required. IDS Group specializes in the Research, Development and Production of isotopic Forensic Marking Technologies. Forensic Marking Technologies, Analytical Geochemistry, Food Authenticity, Stable Isotopes, Raw Material Integration, External Forensic Marking Technologies, Geochemistry Big Data, Laser Induced Based Spectroscopy, Mass Spectrometry, Biofuel traceability, and Traceability Type: | 0 | 0 | 0 | 4 |
 |  EphyX Neuroscience CNS Electrophysiology experts at your service EphyX Neuroscience is a Contract Research Organization (CRO) with a focus on in vitro electrophysiology for preclinical research and drug discovery in the Central Nervous System (CNS) field. Our mission is to empower our clients with the knowledge they need to make informed decisions about their compound selection, by providing comprehensive insights into the mechanisms of action. Our team comprises highly skilled experts who specialize in performing in vitro electrophysiological recordings on a diversity of highly physiological preparations, including both rodent and human models. Our experience and technical expertise ensures that the data we … Type: | 0 | 0 | 0 | 2 |
 | Altevax Biotech Altevax is developing a disruptive immunotherapy technology against cancer Altevax is developing a powerful pioneering immunotherapy technology against cancer. Its patented melanin-based technology has been proven in pre-clinical trials to boost an antigen-specific immune response with Cytotoxic T-lymphocytes (CD8+ Killer T cells), the body’s most powerful defenders. The Altevax immunotherapy technology works with a wide range of peptides. The Altevax technology is complementary to other anti-cancer immune technologies, such as anti PD1s. Altevax is developing an immunotherapy against glioblastoma, currently in advanced pre-clinical development, with Phase 1/2a expected in early 2024. Altevax's partnership with Assistance Publique Hôpitaux de Paris and … Type: | 11 | 3 | 5 | 6 |
 | Minapath Groupe Adène [Automatic translation follows] A healthy life is a life without dust. Minapath has been operating for about fifteen years on the site of the Doua scientific estate in Lyon. It was reintegrated into the Adène group in 2023 and is fully in line with the group's vocation, in response to the needs of patients often faced with medical problems that remain unexplained, sometimes for several years. Minapath Groupe Adène studies the dosage of mineral particles and fibers in human tissues, to highlight a possible overload causing symptoms. Its core business is therefore research into measuring exposure to mineral particles (silica, … Type: | 0 | 0 | 0 | 2 |
 | AmyPore New target, new paradigm, new strategy that address the root cause of Alzheimer, Parkinson, and other proteinopathies AmyPore is a biotechnology company based around the leading science of Pr. Nouara Yahi (University of Aix-Marseillle) and Pr. Jacques Fantini (University of Aix-Marseille and Institut Universitaire de France). Their expertise in molecular neurosciences has led to the discovery of AmyP53, a first-in-class patented nontoxic molecule which tackles a common mechanism of neurotoxicity shared by Alzheimer and Parkinson diseases. The company applies its pioneering computational discovery platform coupled with high performance lipid-protein and protein-protein binding technology and ultrasensitive Ca2+ amyloid pore reporting assay … Type: | 1 | 1 | 0 | 1 |
 | E-PHY-SCIENCE E-PHY-SCIENCE is a service company specialized in In-vivo and In-vitro electrophysiological assays. If you are currently developing a program in CNS disorder, we can help you increase your chances of success. By gathering on the same platform In-Vivo and In-Vitro electrophysiological assays, the E-PHY-SCIENCE team is able to offer you a complete range of studies. These assays can reveal specific abnormalities in many genetic models of human brain disease, as well as the effect of new molecules on normal brain functions. These types of experiment provide insights for new therapies as well as understandings of brain diseases mechanisms. We cover … Type: | 1 | 0 | 0 | 10 |
 | ProGeLife [Automatic translation follows] Innovative research solutions for rare diseases Development of drugs for the treatment of rare genetic diseases with premature or accelerated aging Type: | 0 | 0 | 0 | 9 |
 | ATLANTHERA Bone targeted delivery concept Atlanthera is a drug discovery company focused on bone diseases and bone cancer treatments Our vision: Be the leader in bone-targeted drug delivery to cure bone cancer and metastases Atlanthera can rely on a very high-qualified Team and a worldwide-known experts network Our concept: Bone-targeted delivery of anti-cancer drug www.atlanthera.com Watch our concept in video > https://youtu.be/m3BBWguO6hs Durg discovery, Bone-targeted drug delivery, Bone cancer, and Bone metastases Type: | 2 | 1 | 2 | 10 |
 | GOLIVER THERAPEUTICS Repair the liver without graft GOLIVER THERAPEUTICS is a spin-off from the INSERM and University of Nantes (CRTI UMR1064-ITUN-Nantes Hospital), focused on developing cell-based Advanced Therapy Medicinal Products (ATMP) to respond to an urgent unmet medical need in transplantation. GOLIVER THERAPEUTICS aims to become a Worldwide leader inregenerative medicine in providing the first cell-based therapy product for life-threatening liver failures. Type: | 5 | 1 | 5 | 31 |
 | OCRvet Your partner for comparative medicine studies Oncovet Clinical Research (O.C.R.) is an innovative Contract Research Organization specialized in the conception and management of clinical trials on Dogs & Cats models with naturally occurring pathologies for efficacy assessment of drug candidates for Human Health. O.C.R. innovative offer is at the forefront of ethics of research involving animals since Dogs & Cats included in clinical trials benefit from new therapies developed for Human. O.C.R. main therapeutic fields are Oncology, Inflammation, Cardiology & Neurology. O.C.R. proposes to support Pharma & Biotech in furthering their drug development programs (in preclinical & clinical phases) by … Type: | 3 | 1 | 1 | 21 |
 | METAFORA biosystems AI-Powered Cytometry & Cell Metabolism Profiling At Metafora, we develop innovative and impactful AI-powered cytometry & cell metabolism profiling solutions. We are passionate about cell biology. We leverage our unique cell metabolism and AI-powered data analysis platforms to turn disruptive single-cell technologies into impactful solutions that improve human health. biomarkeurs, cell metabolism, flow cytometry, data analysis, biotechnology, IVD tests, diagnostics, diagnostic tests, cell biology, neurometabolic diseases, metabolic diseases, oncology, multiple myeloma, and research Type: | 18 | 2 | 12 | 35 |
 | Olea Medical - Improved Diagnosis for Life Improved Diagnosis for Life Olea Medical, a provider of advanced MR and CT perfusion imaging post-processing, designs medical imaging applications improving diagnostic processes. Olea Medical was incorporated in 2008, but its history began in 1998, when its founder, then a young medical school student, decided to transition to computer engineering. A trick of life plunged him into the world of medical research to design software dedicated to the processing of medical images for hyper acute stroke – the ancestor of PerfScape and NeuroScape. After a ten-year career in military informatics, the idea of Olea Medical emerged with three other engineers, … Type: | 8 | 0 | 1 | 122 |
 | EG 427 Pinpoint Gene Therapy At EG427 our unique, non-replicative Herpes Simplex Virus type 1 (HSV-1) based vector platform delivers, with pinpoint precision, highly selective, durable expression of disease modifying transgenes to address prevalent diseases in neurology. Our lead asset EG110A, for the treatment of neurogenic bladder dysfunction, has received IND clearance in June 2024 from the US FDA. Our revolutionary approach to the treatment of this disease aims at providing patients with a comprehensive, long-term solution to their bladder management, through a highly selective molecular biology approach overcoming the drawbacks of current standard of care. Our HQ and labs are in … Type: | 2 | 2 | 0 | 23 |
 | Rarecells Detect and defeat cancer from its start through a simple blood draw. Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research. Rarecells® Diagnostics was created in 2010 by Patrizia Paterlini Brechot, Professor of Cell Biology and Oncology, in order to make the scientific and technological advances developed by her team available to research teams and patients. Rarecells® Diagnostics’ core product is the patented ISET® (Isolation by SizE of Tumor cells) Technology. Rarecells® Diagnostics has the exclusive license of patents belonging to the French Public Institutions University Paris Descartes, Assistance Publique … Type: | 1 | 1 | 0 | 22 |
 | Scipio bioscience Single-cell sequencing on every benchtop Scipio bioscience had to cease its operations on 18/09/2024. At Scipio bioscience we were passionate about empowering every researcher to discover the molecular mechanisms of life for better health and a sustainable world. Enabling deeper insights into disease understanding, Scipio wanted to boost the access to and increases the pace of discoveries with its Asteria benchtop kit for easy scRNA-seq sample preparation and its Cytonaut intuitive cloud-based data analysis software for biologists and bioinformaticians alike. Scipio provided all researchers with empowered autonomy to embrace the next step in single-cell, working with unaltered transcriptomic data for … Type: | 4 | 2 | 3 | 14 |
 | Innoskel Developing novel therapies for rare bone diseases Innoskel is a pioneering platform biotechnology company developing therapies for rare bone diseases. Innoskel's first asset is a treatment option for a group of rare skeletal disorders collectively known as type 2 collagenopathies, the most severe of which with symptoms present from birth is Spondyloepiphyseal Dysplasia congenita (SEDc), the second leading cause of dwarfism worldwide. Innoskel’s lead gene therapy asset for SEDc has demonstrated good efficacy in proof-of-concept studies. The company’s fundamental mission is to improve the lives of patients living with rare bone disorders and to answer their unmet needs, keeping their … Type: | 8 | 7 | 1 | 7 |
 | Invectys Invectys a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers Invectys, Inc. is a privately owned clinical-stage company, headquartered in Houston, Texas, which is developing a new generation of First-in-Class products for cancer patients. Invectys has two wholly owned subsidiaries, Invectys, SAS (Paris) which is focused on scientific research and innovation and Invectys USA, Inc. (Houston) which is directing the clinical development of the Company’s lead HLA-G product. Since 2010, Invectys has raised over $60 million in private funds to develop its two innovative platforms of immunotherapy products which target “universal” tumor antigens. oncology, immunotherapy, … | 1 | 1 | 0 | 22 |
 | Evora Biosciences First-in-class immunomodulatory peptides. Evora Biosciences develops novel immunomodulatory peptides with the aim to bring first-in-class treatments to patients in areas of high unmet need. immunodermatology, peptides, inflammatory diseases, respiratory diseases, inflammation, and immunomodulation Type: | 5 | 3 | 2 | 8 |
 | Orphalan At Orphalan we strive to develop rare disease treatments to improve patients lives. Transforming Rare Disease Treatment At Orphalan we identify, develop, and provide access to innovative treatments for patients with rare diseases to make a positive and meaningful difference. | 3 | 2 | 2 | 111 |
 | Egle Therapeutics Modulating T-regulatory cells to balance immunity Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones. Type: | 2 | 1 | 1 | 38 |
 | Step Pharma Developing selective inhibitors of CTPS1 for patients with cancer and auto-immune diseases Step Pharma is the world leader in the discovery and development of inhibitors of CTPS1 (cytidine triphosphate synthase 1) for the treatment of cancer and autoimmune diseases. Step Pharma’s lead program dencatistat (STP938) is a first in class, potent, selective, oral inhibitor of CTPS1 with demonstrated anti-tumor activity. Dencatistat entered clinical development in 2022 in a PhI/II study for the treatment of relapsed and refractory T-cell and B-cell lymphoma. More recently a solid tumour study was started focused on ovarian cancer using the concept of synthetic lethality and … Type: | 1 | 0 | 0 | 16 |
 | MAbSilico The only TechBio providing computationally designed antibodies through AI with biological validations associated MAbSilico is a TechBio company developing and providing AI-based solutions for antibody drug design and discovery. We help biotech and pharma companies to leverage antibody discovery risks by providing computational candidates in days which are designed and characterized in silico and validated with state-of-the-art biological technologies. While MAbSilico combines 3D modeling, interaction simulation and linear sequences analysis, the antibody drug candidates are defined through their epitope, affinity, off-target risk, cross-species reactivity and developability assessment to be ready for biological activity evaluation. Using NLP technologies we gather information … Type: | 18 | 5 | 11 | 13 |
 | CryoCapCell Be your next correlative microscopy step Created in 2013, CryoCapCell® designs, develops and globally markets the CryoCapsule®: a unique, proprietary technology for high-pressure vitrification. CryoCapCell constantly innovates to make your Correlative Light and Electron Microscopy experiments faster, simpler and more reliable. Thanks to the highly innovative nature of its technologies, CryoCapCell has developed partnerships with leading scientific research institutions, including Institut Curie and the Mechanical and Materials Engineering Laboratory (PIMM) at Arts et Métiers. www.cryocapcell.com correlative light and electron microscopy, high pressure freezing, cryocapsules, live cell imaging, electron microscopy, in resin fluorescence preservation, and CLEM Type: | 5 | 1 | 4 | 7 |
 | BOO$TER health [Automatic translation follows] BOOSTER health is a crowdfunding platform for innovative companies in the health, life sciences and well-being sectors, specializing in fundraising between €200,000 and €1 million. BOOSTER health's objective: to enable simpler and more direct investment in French start-ups and SMEs in the health, life sciences and well-being sectors. We select, analyze and negotiate the best conditions for entering the capital of these companies to facilitate the investment procedure. The BOOSTER health platform offers a financing solution far from the traditional circuit and creates a new investor-company relationship. In order to contribute to the development of a new … Type: | 0 | 0 | 0 | 0 |
 | SMALTIS Together, make science greater! Smaltis is a French laboratory that contributes and participates effectively in the development of health and well-being products. Specialized in microbiology and molecular biology, Smaltis offers tailor-made in vitro services in the field of antimicrobials, microbiota, bioproduction and genomics. As a true expert, Smaltis accompanies its scientific services with genuine and enlightened advice. 📧 contact@smaltis.com 🌐 www.smaltis.com strains characterization, microbiota exploration, antimicrobial efficacy, cytotoxicity, antibiotic resistance mechanisms, microbiology, molecular biology, cellular biology, bacterial strain engineering, and plasmids construction | 13 | 2 | 8 | 10 |
 | Clinfile Could computing company specialised in clinical research Clinfile, a MultiHealth Group company, is a Contract Research Organisation (CRO) specialised in cloud computing solutions which provides a full range of eTools for clinical data collection and management. Clinfile is now considered in the top 3 of cloud computing companies specialised in clinical research, The Clinfile solutions have become essential for setting up and following of international clinical trial. Clinfile benefits from the support of Multihealth Group companies and can associate cloud computing services with CRO services for a complete offer : - CLINACT expert in the management of national and international … Type: | 10 | 0 | 10 | 4 |
 | Medical Device Engineering MEDICAL DEVICE ENGINEERING S.A.S to bring innovators the missing link in the development of their medical devices. We created MEDICAL DEVICE ENGINEERING S.A.S to bring innovators the missing link in the development of their medical devices and disposables. The concept of your therapy, or surgery has been proven from the medical point of view (PoC) and you need a device? Or you may simply have an idea and do not know where to start to make it concrete? Our Philosophy: A team composed of both Scientists & Engineers (plastics processing) to better understand each other, and to make … Type: | 0 | 0 | 0 | 3 |
 | ACTIV'INSIDE Science Inside, Claims Outside ACTIV'INSIDE: Science inside, Claims outside ACTIV'INSIDE is a French foodtech company specialized in the development, production and marketing of nutraceuticals, from natural active ingredients and botanical extracts, to contract manufacturing and private labelling services for the health nutrition industry. ACTIV'INSIDE develops innovative active solutions, available as ingredient or as ready-to use formulation for private labelling, supported by scientifically proven efficacy, clinical studies and proprietary validated claims. Each formulation combines bioavailable ingredients with complementary mechanisms of action. ACTIV'INSIDE also offers a full range of standardized premium botanical extracts, with a strong expertise in grape and saffron. Since … Type: | 8 | 4 | 8 | 63 |
 | Pharm'image #Pharmaco-imaging, #nuclear medicine, #PET/MRI, #Radiochemistry, #Preclinical models Created in 2008 in Dijon, Pharm’image is a regional center of excellence in Pharmaco-imaging. Unique in France, it brings together hospitals, biotechnology, and pharmaceutical companies, to offer state-of-the-art of functional and molecular imaging technologies (MRI, PET, SPECT, CT), ranging from small-animal scale for preclinical experimentation to clinical exploitation Its aim is to deploy cutting-edge medical imaging technologies to evaluate biomarkers that can be used to track treatment efficacy and select the active and most promising drug candidates. imaging, preclinical evaluation, pharmacology, molecular imaging, nuclear medicine, radiochemistry, bioconjugation, translational research, in vivo pharmaco-imaging, First … Type: | 0 | 0 | 0 | 1 |
 | SUPERBRANCHE Nanomaterials as Nanomedicines: let's play collective! SUPERBRANCHE : Nanomedicine as a breakthrough to treat cancer We bring answers to the following issue: intratumoral injection of nanomaterials implying both accessibility and detection of the tumor beforehand. We position ourselves as a producer dedicated to the synthesis of architectured nanomaterials as simple as possible and of controlled size. Our modular technology platform presents both therapeutic and diagnosis applications. It consists in a magnetic nanoparticle coated by a tailor made branched architecture. Thanks to their optimized shape and stability, our compounds are well tolerated and can be administered intravenously, thus helping to the … Type: | 14 | 6 | 7 | 10 |
 | PKDERM Smart innovative solutions in dermatology and respiratory diseases Welcome to PKDERM - Your Trusted Partner for In Vitro Safety and Efficacy Solutions. PKDERM is a leading provider of innovative and effective solutions for in vitro efficacy and safety testing of new products. Our team of experts has years of experience in the industry, and we are committed to delivering the highest level of quality and support to our clients. At PKDERM, we specialize in in vitro safety and efficacy testing, using a range of biological models such as 2D and 3D human skin equivalent models, excised human skin, 2D and … Type: | 5 | 2 | 4 | 2 |
 | DiaDeep Every patient matters, every decision counts ! Are you familiar with that moment of hesitation when facing a critical decision, knowing that much is at stake and time is of the essence? This daily challenge is particularly acute for pathologists and oncologists worldwide, especially when making treatment decisions for cancer patients. A minor error in judgment can have far-reaching consequences on numerous lives. To support pathologists and oncologists in these critical decisions, we have developed Ai Copilot applications. These tools assist in decision-making, biomarker quantification, and prognosis prediction, utilizing AI technology and histology slides across various cancers such as breast … Type: | 29 | 5 | 10 | 10 |
 | Matricis.ai Artificial Intelligence for women's health. Matricis.ai brings the best science and cutting-edge machine learning algorithms to endometriosis research. We collaborate with radiologists to co-create medical-grade applications with the goal of improving diagnosis accuracy and democratizing the world's best specialists' expertise for all patients while saving time and reducing medical errancy. Type: | 18 | 7 | 12 | 4 |
 | STH BIOTECH Unlocking the access to innovative ingredients and APIs from cannabis, thanks to plant biotechnology. STH BIOTECH develops unique and reliable plant-biotech process to produce cannabinoids at high yield & low cost. Type: | 14 | 6 | 12 | 12 |
 | CGenetix From hope to reality Young start-up that aims to revolutionize precision medicine by developing innovative and non-invasive diagnostic tests dedicated to monitoring patients with various pathologies. CGenetix is mainly focus on the development of its first diagnostic test dedicated to kidney graft monitoring in transplant patients. biologie moléculaire and Bio-informatique Type: | 9 | 4 | 7 | 4 |
 | Gene&GreenTK Enzymes for agricultural transition Gene&GreenTK (GGTK) is a biotech company created in 2013 and incubated in the IHU of Marseille. The work of GGTK is dedicated to the development and engineering of innovative enzymes isolated from microorganisms living in extreme environments. Enzymes developed by GGTK have two main applications: - Anti-virulence and anti-biofilm for the development of sustainable alternative to conventional antimicrobial agents targeting applications in agriculture, animal nutrition or anti-fouling. - Bioremediation of organophosphorus chemicals for the degradation of insecticides and chemical warfare agents. enzyme, protein engineering, Quorum quenching, organophosphorus decontamination, bioremediation, anti-fouling, biofilm, bacterial virulence, biocatalysis, extremophiles, lactonase, … Type: | 5 | 1 | 0 | 11 |
 |  Isomab Ltd IsomAb is taking a different approach to identify, evaluate and develop isoform specific antibodies to treat disease where patients currently have limited or no treatment options. IsomAb is developing isoform specific antibodies and it has identified, using a combined bioinformatics/knowledge-based platform approach, ISM-001 which specifically inhibits the VEGF-A165b isoform of Vascular Endothelial Growth Factor-A (VEGF-A); based on 20 years of research by our two Founders, the evidence shows reducing serum levels of VEGF-A165b is key to ensuring new blood vessel formation in patients with ischemic disease. Type: | 0 | 0 | 0 | 14 |
 | King Hussein Cancer Foundation and Center The King Hussein Cancer Foundation- Governing Body (The Foundation) is an independent, non-governmental, not-for-profit institution founded in 2001 by Royal Decree to combat cancer in Jordan and the Middle East region. The Foundation is governed by a Board of Trustees comprised of a dedicated group of prominent volunteers chaired by HRH Princess Ghida Talal. The Foundation is the legal umbrella organization responsible for: (1) The King Hussein Cancer Foundation- Fundraising, Advocacy and Development (KHCF). KHCF is the largest community-based organization in Jordan dedicated to combating cancer. KHCF’s work focuses on fundraising and development, global advocacy, public awareness on early detection … Type: | 2 | 1 | 1 | 2,172 |
 | IZMIR BIOMEDICINE AND GENOME CENTER (IBG) Hayal Et, Araştır, Keşfet Izmir Biomedicine and Genome Center (IBG), which was established within the scope of law no. 6550 as one of the first four research infrastructures of Turkey, has been operating since 2014. Founded by members of Dokuz Eylul University to establish a regional center of attraction for science, technology and innovation in Izmir, IBG’s main objective is to carry out powerful research on biomedicine and genome sciences, to develop products based on medical and pharmaceutical biotechnologies using its workforce and technical infrastructure, and thus, to contribute to universal science and the transformation of our national industry. IBG … Type: | 0 | 0 | 0 | 256 |
 | CENTOGENE The essential biodata life science partner for rare and neurodegenerative diseases CENTOGENE’s mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. We integrate multiomic technologies with the CENTOGENE Biodatabank – providing dimensional analysis to guide the next generation of precision medicine. Our unique approach enables rapid and reliable diagnosis for patients, supports a more precise physician understanding of disease states, and accelerates and de-risks targeted pharma drug discovery, development, and commercialization. Biochemical diagnostic test, Genetic diagnostic test, Rare diseases, Congenital diseases, Oncogenetics, Clinical and medical interpretation of genetic data, Next Generation … Type: | 25 | 0 | 22 | 429 |
 | ONCOLille [Automatic translation follows] Gathering interdisciplinarity to fight cancer! The Lille Interdisciplinary Cancer Research Institute, called ONCOLille, was created on January 1, 2020. The institute will be located on the university hospital campus at the interface of the 2 healthcare institutions: the Lille University Hospital and the COL. Its location is highly strategic in order to offer a showcase for cancer research in Lille and Hauts de France, at the entrance to the university hospital campus, open to the public, and to bring together fundamental researchers and clinicians in one place in order to promote the transfer of research to the … Type: | 3 | 3 | 0 | 32 |
 | NAOS (Bioderma - Institut Esthederm - Etat Pur) Pioneer of Ecobiology. The company behind BIODERMA, Institut Esthederm and Etat Pur. Made in France products. When he created the first BIODERMA and Institut Esthederm products in 1977, Jean-Noël Thorel, a pharmacist-biologist, paved the way for active cosmetics by integrating biology into cosmetics, with the aim of changing the paradigm. Present today in more than 100 countries, NAOS has chosen a single design and manufacturing site, NAOS Les Laboratoires, in Aix-en-Provence (France), in order to control the quality and unique design of its products. NAOS brands - BIODERMA, Institut Esthederm and Etat Pur - claim a unique approach: ecobiology. A … Type: | 15 | 6 | 10 | 3,381 |
 | Just - Evotec Biologics Designing and applying innovative technologies to dramatically expand global access to biotherapeutics. Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is … Type: | 6 | 2 | 5 | 579 |
 | Cofactor Genomics The Leaders in RNA Cofactor Genomics’s mission is to create diagnostics that have the ability to predict the patients that can benefit from immunotherapies. Using more insightful multidimensional biomarkers created with RNA and machine learning, Cofactor’s diagnostics offer greater predictive power than any current test. Instead of searching for isolated, single-analyte biomarkers or DNA mutations, Cofactor’s products create multidimensional biomarkers that better capture the complex immune response at the site of a tumor. Cofactor Genomics empowers clinicians to be better informed while making treatment decisions to improve patient outcomes. RNA, RNA-seq, NGS, Bioinformatics, and Diagnostics Type: | 3 | 0 | 1 | 9 |
 | Inmedical Therapeutics Innovation in medical needs. Inmedical Therapeutics es un fabricante de productos médicos y soluciones en formato hidrogel ubicado en Vitoria. Biotecnología, Endoscopia, Farmacéutica, and Producto Médico Type: | 0 | 0 | 0 | N/A |
 | Bioprocesia Proteína sostenible para alimentar al mundo 🌎 Circular feed for the world 🌎 We offer sustainable and customizable protein to the animal feed market Biotecnología, Bioprocesos, Biomasa, Proteína, Alimentación animal, Hipoalergénico, Adaptable, Customizable, Circular economy, Economía circular, Biotech, Fermentación, Fermentation, Bioprocess, Biomass, Animal feeding, Protein, Alternative protein, and Proteína alternativa Type: | 0 | 0 | 0 | 4 |
 | Newronika S.p.A. Building Brain Computers Building Brain Computers Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normal daily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups … Type: | 2 | 1 | 0 | 23 |
 | Shuimu BioSciences Cryo-EM & AI Powered Drug Discovery Powerhouse. Shuimu is a rapidly evolving global cryo-EM & AI platform for early drug discovery, founded in 2017 and headquartered in Beijing, China. Shuimu drives innovation to accelerate the development of innovative drugs. Shuimu leverages the power of cutting-edge cryo-EM & AI technology to help its partners gain key structural insights into the target proteins and complexes. The team consists of top talents with global backgrounds in the field of structural biology, machine learning, protein science, and drug chemistry. Learn more about Shuimu and check out its cryo-EM precision imaging platform by visiting shuimubio.com … Type: | 0 | 0 | 0 | 26 |
 | PetMedix R&D stage veterinary therapeutics biotechnology company based in Cambridge, UK The PetMedix channel will soon be discontinued as we join forces with Zoetis. Follow the Zoetis channels to stay connected and for the latest updates! Biotechnology, Drug Development, Drug Discovery, Therapeutic Antibodies, Monoclonal Antibodies, Companion Animal, Veterinary Medicine, and Research and Development Type: | 8 | 0 | 7 | 16 |
 | Mosanna Therapeutics A Swiss Biotech company with a commitment to improving patient outcomes and quality of life in high unmet need diseases Mosanna is a Swiss Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. We carefully select innovative medicines for further development using the best contract research organisations in the specific specialised field. Our first goal is to bring an effective and well tolerated medicinal nasal spray to Metabolic Obstructive Sleep Apnea patients. Type: | 0 | 0 | 0 | 7 |
 | PENTABIOL Animal Health We develop innovative products for feeding animals for human consumption, naturally improving their digestive function, defences and productivity. Thus, we also improve our diet and our quality of life. biotenología, animal, alimentación, and piensos Type: | 0 | 0 | 0 | 8 |
 | ASTRA Therapeutics Precision Drugs against Eucaryotic Pathogens ASTRA Therapeutics is a Drug Discovery company with a mission to design and develop novel, precision engineered drugs against a whole range of Eukaryotic Pathogens. Type: | 1 | 0 | 0 | 4 |
 | Gedea Biotech AB Developing antibiotic free treatment for vaginal infections Gedea Biotech develops pHyph to treat and prevent recurrence of bacterial vaginosis. Bacterial vaginosis (BV) is a very common condition with a prevalence of 10-30% for women of childbearing age. The symptoms can be very disturbing and include an often profuse thin, white, “fishy” smelling vaginal discharge. Standard treatment consists of antimicrobials, but recurrence rate is 15–30 % within 3 months. pHyph will treat the infection and prevent recurrence without the use of antmicrobials. Antimicrobial resistance is one of the World Health Organisation’s top ten threats to global health and research into novel … | 0 | 0 | 0 | 16 |
 | Invitris A startup using Synthetic Biology to innovate the way we develop entirely novel classes of protein-based drugs. Our patent-pending biotech platform, Phactory, makes designing synthetic proteins 10,000x more effiicent and reduces the material costs by 100x. We are leveraging Phactory to develop the newest classes of protein-based drugs, such as the next generation of antibiotics. Type: | 0 | 0 | 0 | 21 |
 | Beckley Psytech Transforming psychedelics into effective and rapid-acting medicines for neuropsychiatric conditions. Beckley Psytech is a private, clinical-stage biotechnology company dedicated to improving the lives of people suffering from neuropsychiatric disorders by transforming psychedelics into effective and rapid-acting medicines. Our vision is for clinically validated psychedelic medicines to be integrated into modern medical practice in order to help patients living with depression and other profoundly debilitating neuropsychiatric conditions with a high unmet need. Founded in 2019, and underpinned by more than two decades of pioneering scientific research from the Beckley Foundation, we combine world-leading psychedelic science with deep neuropsychiatric drug development expertise … Type: | 6 | 1 | 5 | 64 |
 | Ochre Bio Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com. | 16 | 3 | 15 | 61 |
 | contextflow Comprehensive computer-aided detection software for lung cancer, ILD & COPD contextflow is your comprehensive solution for all things chest CT: lung cancer, ILD and COPD. Our computer-aided detection system ADVANCE Chest CT offers lung nodule detection & tracking of changes over time, quantitative and qualitative analysis of 8 key image patterns, and 3D image search for 19 image patterns. By integrating new technology from partner RevealDx, nodules can be further characterized, detecting lung cancer earlier and reducing costs (JACR 9/22). contextflow ADVANCE Chest CT includes a TIMELINE feature that even quantifies and visualizes nodules over time, allowing physicians to follow … Type: | 10 | 2 | 7 | 36 |
 | Cellestia Biotech Cellestia Biotech is pioneering innovative therapeutics based on novel modes of action to treat autoimmune diseases and multi-drug resistant cancers. Our clinical stage drug candidate, CB-103, has demonstrated both safety and biological activity in humans. Along with ongoing Phase 2 IITs for multi-drug resistant cancers, CB-103 is also poised to enter a Proof-of-Concept clinical study for graft-versus-host disease (GvHD) Biopharma, Oncology, Precision Medicine, Small Molecules, Targeted Therapy, Biotech, Cancer Therapy, Transcription Factors, Autoimmune Disorders, and Inflammatory Disorders Type: | 3 | 0 | 0 | 15 |
 | PinPoint Data Science Early cancer detection and healthcare system optimisation. PinPoint Data Science is a company formed around a team of world class data scientists who have developed a machine learning blood test that helps doctors triage patients by their risk of cancer: The PinPoint Test. Our ambition is to distill the vast and ever-increasing complexity of medical data into simple tools enabling clinicians to make better choices for their patients. Datascience, Cancer, Machine Learning, Artificial Intelligence, Diagnostics, Statistical Modelling, Clinical Support, and Cancer detection Type: | 3 | 0 | 2 | 14 |
 | Reliefband Technologies LLC The Anti-Nausea Wristband helping you overcome life's uncomfortable moments. Reliefband® is a world leader in neuromodulation creating the first FDA-cleared, clinically proven wearable device that treats nausea and vomiting associated with sea sickness, motion sickness, migraines, anxiety, and more. Worn on the wrist, Reliefband's patented technology stimulates a nerve that sends a message to the brain to "turn off" nausea, providing quick and effective relief without any unwanted side effects. Type: | 1 | 0 | 1 | 8 |
 | Okomera Automated 3D organoid screening technology We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity Type: | 24 | 8 | 15 | 23 |
 | phagos Unleash Bacteriophage Potential We founded Phagos out of a common ideal: to use entrepreneurship as a force for positive change. Antibiotic resistance is an urgent and unaddressed global challenge that was declared a top 10 threat to humanity by the World Health Organisation. Experts project that this 'silent pandemic' could kill 10 million people per year by 2050. At Phagos, we're dedicated to finding a solution. Our approach is evolutionary—we harness the natural predator of bacteria, the bacteriophage, to cure these life-threatening infectious diseases. Bacteriophages can become an efficient and sustainable alternative to antibiotics. But this is just a fraction … Type: | 13 | 6 | 11 | 24 |
 | Rime Bioinformatics Making high performance bioinformatics accessible. Rime Bioinformatics is a research and development biotechnology company with a focus on bioinformatics. We develop services to speed up medical, agronomic and veterinary research. Our technologies grant in-depth view of bacterial and bacteriophage genomes, which is an essential prerequisite in the R&D process that leads a phage to market. We work hard to make high-performance bioinformatics accessible and promote a safe use of phage therapy for the patients and the environment ! Bioinformatics, Phage, Bacteriophage, Genomics, Bacteria, Phage Therapy, and metagenomics Type: | 2 | 2 | 2 | 4 |
 | PEP-Therapy Innovative peptides as targeted therapies for oncology PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, first drug candidate, is a pro-apoptotic agent which has demonstrated anti-tumor efficacy in a number of pre-clinical models and a good safety profile. PEP-010 is currently evaluated in a Phase Ia/b clinical trial in patients with recurrent and/or metastatic solid tumors. PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors. cell penetrating peptide, protein-protein interaction, targeted therapies, oncology, clinical trial, and cancer Type: | 5 | 4 | 2 | 15 |
 | Microphyt Fostering a Blue Future ! Created in 2007 near Montpellier-France, Microphyt develops and markets unique microalgae-based bioactives using breakthrough technologies and processes. Developed over 10 years, and endorsed by key customers, partners and investors, these bioactives are addressing the nutraceutical & cosmetic industry sectors. photobioreactor, microalgae, nutrition, biotechnology, Blue Future, nutraceuticals, Made in France, Cosmetics, innovation, better living, patented technology, natural ingredients, and bioactive compounds Type: | 30 | 14 | 14 | 62 |
 | GenSight Biologics Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics for retinitis pigmentosa, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber’s Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible low vision and legal blindness in … Type: | 16 | 6 | 11 | 36 |
 | Affilogic Discovering and developing Nanofitins® through collaboration with worldwide pharma industry leaders Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector. These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule. Affilogic has designed Nanofitins® against 60+ targets to date, … Type: | 4 | 4 | 1 | 37 |
 | ONLYNNOV Insurance broker for innovative companies : "we insure Frenchtech Worlwide" Insurance broker specializing in Innovative Compagnies risk management and insurance. We created a range of insurance products specificaly for your univers : - onlyNUM for software editors, cloud provider, digital services providers and web economy - onlyMED for Medical industries, life sciences, Medtech and devices, Biotech, Pharmaceuticals - onlyIOT for the Internet of Things, Mecatronics and Robotics Assurance des entreprises innovantes, Biotech, Medtech, Dispositifs Médicaux, Pharma, Numérique, Web, Cloud, Editeurs de Logicels, ESN SSII, objets connectés, Robotique, Robots, Mécatronique, Véhicules autonomes, Nouvelles mobilités, RC promoteur de recherche biomédicale, Responsabilité des … Type: | 27 | 2 | 25 | 13 |
 | GOSHABA [Automatic translation follows] Make recruiting fun, fast and fair! Goshaba makes recruiting more reliable, fun and fair (*equitable). Goshaba was created in 2014 by Djamil and Minh, two champions of the video game industry, and Camille, a researcher and world expert in neuroscience. Combining video games, data and neuroscience, Goshaba enables skills-based recruitment that truly respects candidates through a unique candidate experience and the opportunity to obtain an interview regardless of age, social origin, gender, education, etc. Goshaba has won awards at the Concours Mondial d'Innovation, digital innovation competition, Techinnov, Vivatech, EDF energy diversity award, etc. and is now supported … Type: | 50 | 12 | 33 | 20 |
 |  Coral Biome PHARMA CORAL BIOME PHARMA Live cultured corals for Drug discovery Coral Biome is a research and development company dedicated to the discovery of marine natural products of interest for major public health issues such as cancer, inflammation and multi-drug resistant infectious diseases. Our multidisciplinary team of research and worldwide network of collaborators gathers a unique set of competitive expertise including, aquaculture, marine biology, chemistry, cell biology and cancerology to successfully isolate marine natural products and test their biological activity. We maintain a large-scale untapped reservoir of coral species to preserve endangered species, sell corals for aquarium trade (http://www.coralbiome.com/aquaculture/) and provide research … Type: | 1 | 1 | 0 | 2 |
 | Joovence Give your smile a second youth. Originally a network of dental practitioners devoted to making orthodontics affordable to patients, Joovence has decided to offer its in-house technology to any practice looking to offer better patient care through digitalisation. Joovence’s proprietary platform is designed to optimize conversion by facilitating the patient journey. It uses CRM logic combined with payment solutions and online treatment monitoring to increase practices' conversion rates. Joovence can combine this platform with premium dental aligners packaged without hidden costs and priced in a granular manner related to the duration of treatments. Finally, Joovence can assist dental chains in … Type: | 1 | 0 | 1 | 5 |
 | DelleD - LaFleur [Automatic translation follows] Serving patients and research. French hub for medical cannabis and dermo-cosmetic innovation Created in 2014 by a patient, DelleD is developing LaFleur Laboratories, the first French pharmaceutical laboratories specializing in medical cannabis & hortimind, an AI-assisted plant production solution. LaFleur aims to promote research and development of medical cannabis in France and internationally and to defend the evolution of the legal framework relating to the production, cultivation and use of cannabis for medical use. The laboratories cultivate, transform, control and manufacture medicinal products based on medical cannabis as part of research and development in France. Experts in … Type: | 17 | 4 | 12 | 11 |
 | ScreenACT [Automatic translation follows] Tomorrow's research is today ScreenACT is a laboratory specialized in screening techniques using artificial intelligence to analyze and optimize your clinical trials and accelerate your therapeutic research programs. Artificial Intelligence, Screening, Innovation, Digital, and HealthTech Type: | 18 | 5 | 11 | 6 |
 | Smart Hands-on [Automatic translation follows] Develop learner engagement through stimulating training experiences! Smart Hands-On provides a SaaS platform to train enterprise talents using gaming, simulation and teamwork. Through innovative design and modeling, people are involved in the Smart Hands-on environment transforming them into active player of their learning path. Software development, Training through practice, Gamification, digital learning, business game, micro learning, mobile learning, collective intelligence, engagement, and neuroscience Type: | 4 | 2 | 0 | 4 |
 | Cog'X [Automatic translation follows] Adapt work to human functioning thanks to cognitive sciences. Cog'X is a consulting agency that supports organizations with the ambition of reconciling development and well-being at work. Our team of doctors in neuroscience draws on research to sustainably preserve and reveal the cognitive resources of individuals. We intervene in the context of seminars, training courses, e-learning modules and carry out diagnostics to identify obstacles and propose levers for action within your organization. Management of emotions, concentration, work rhythms, collaborations, learning, etc.: we implement tools and methodologies to raise awareness, train and co-construct working methods that allow individuals … Type: | 25 | 3 | 18 | 12 |
 | MImAbs SAS Innovative start up developing monoclonal antibodies in cancer and inflammatory diseases MImAbs is an innovative start-up specialized in immunotherapy. Our goal is to develop monoclonal antibodies in cancer and inflammatory diseases for third parties (academics, pharmacuetical companies, biotechnologies, etc.) Anticorps monoclonaux, Immuno-pharmacologie, Génération et bioproduction d'anticorps, and Génération d'immunoconjugués Type: | 4 | 3 | 2 | 33 |
 | Lamina Therapeutics Developing innovative implantable medical devices for orthopaedic applications Lamina Therapeutics is a pioneering biotechnology company, developing innovative medical devices promoting patient's active live. Lamina’s technology consists of a three-dimensional biodegradable wound dressing with nano-reservoirs including active therapeutics in combination with patient’s own stem cells. This unique multifunctional approach offers a variety of potential applications addressing unmet medical needs in the field of orthopaedics, maxillofacial and periodontal lesions. Lamina’s lead product lamina.ONE, offering a hybrid therapeutic action for the repair of cartilage as well as subchondral bone for a full recovery of the articular function, is expected to enter phase I/II … Type: | 1 | 0 | 1 | 4 |
 | GLOphotonics Hollow-core fiber technology & Gas photonics GLOphotonics SAS (or 'GLO' for short) is a French company based in Limoges. GLO is set up to commercialize hollow-core photonic crystal fiber (HC-PCF) and their functionalised form Photonic MicrocellsTM (PMC). GLO products are built upon its proprietary and disruptive specialty fiber technology and gas photonics. GLO is extending the capabilities of the HC-PCF and PMC even further by working with laser developers and system integrators, and with CNRS-University of Limoges joint Research Institute XLIM to keep giving its technology a continuous innovative edge. Photonics, Lasers, Precision Timing, Hollow-core Fibers, ultrafast lasers, and microcell | 7 | 6 | 4 | 14 |
 | Flash BioSolutions CDMO expert specialized in gene delivery Flash BioSolutions is a World-class CDMO expert in lentiviral vector manufacturing : With our continuum from research to the clinic we support you throughout your projects from R&D to GMP grade. We provide purified and highly concentrated particles from small scale to large scale with the same vector specifications. Flash BioSolutions provides integrative lentiviral vectors and RNA particles. Lentiviral vectors - LentiCare® : Conventional lentiviral vectors, which lead to DNA integrated into the genome, are a leading delivery method for applications which require a stable and long-term gene expression. Ideal for Gene Therapy and … Type: | 22 | 3 | 9 | 50 |
 | Cell-Easy Your science-driven CDMO dedicated to Cell Therapy Cell Easy is a rapidly growing Contract Development and Manufacturing Services organization (CDMO) with a dedicated focus on Advanced Cell Therapies. Established in 2017, Cell Easy's commitment extends beyond development and manufacturing; it also places a strong emphasis on regulatory and analytical aspects. Cell Easy offers a comprehensive suite of services, including process development, process scale-up, cGMP manufacturing, and analytical support for immune cells (engineered CAR-T, NK cells, and non-engineered cells) as well as adult stem cells (MSCs, iPSCs, and Exosomes). Our company has achieved significant milestones, such as advancing programs to Phase … Type: | 0 | 0 | 0 | 41 |
 | CapEval Pharma CapEval Pharma, founded in 2010, provides pharmaceutical consultancy services from early pre-clinical to clinical development, specifically in the sectors of Safety, Toxicology, Pharmacology, Ophthalmology, ADME/PK, analytical development, QA, CMC-Regulatory Affairs and Compliance. In addition, CapEval provides expert assessment for due diligence, veterinary drugs, cosmetics, agrochemicals and chemicals as well as staff training. Drawing on > 60 years of combined international experience, we are a team of highly qualified pharmaceutical consultants, fluent in 5 languages. We provide scientific advice and training to identify the best approach to move your projects quickly through development and onto the commercial market. With experience working … Type: | 3 | 2 | 0 | 2 |
 | Cancer Contribution [Automatic translation follows] Actor of democracy in health Our mission is that each of the actors concerned by cancer (patients, caregivers, doctors, political leaders, researchers, the associative world, citizens), with their expertise, participates in the co-construction of a new vision around the disease and its impacts on society. The new vision resulting from this process is the basis for political proposals and the development of professional practices. Our objective is twofold: 1/ to bring together for the first time a community of different and complementary experts. 2/ To build together avenues of reflection and propose solutions for the improvement of … Type: | 13 | 4 | 9 | 5 |
 | BIO-LUTIONS Renaturing the World of Materials BIO-LUTIONS is pioneering the dry molding production technology to create sustainable packaging solutions made in Germany. Our fibre-based packaging products are completely recyclable (CEPI certification) and an affordable and scalable alternative to single-use plastic. Circular Economy Type: | 0 | 0 | 0 | 13 |
 | FIRALIS S.A. Within Basel neighbourhood and at the very heart of Europe (the triple border of France, Germany and Switzerland), Firalis is a pioneering biotechnology company, active in discovery, development and qualification of biomarkers (BM). 1) BIOMARKER PRODUCTS Firalis develops BM-based diagnostic, prognostic and theranostic tools: ● RUO Kits (Research-Use-Only), based on validated innovative biomarkers ● IVD Tools (In Vitro Diagnostic), based on a combination of clinically qualified biomarkers 2) BIOMARKER R&D ● Development of proprietary BMs - Cardiovascular, Inflammatory, Autoimmune and Neurology ● Drug Safety & Drug Efficacy ● Patient Stratification ● Personalized Medicine 3) BIOMARKER-RELATED CRO SERVICES BM Discovery for … Type: | 18 | 4 | 4 | 33 |
 | Beta Innov [Automatic translation follows] Development in Immunology and Cancerology of innovative drugs with curative potential. Beta Innov SAS is an innovative pharmaceutical Research and Development company, created in March 2009 by families of patients. Beta Innov aims to achieve a major therapeutic leap in the treatment of autoimmune diseases and Glioblastoma by using a physiological (Immunology) or metabolic (Glioblastoma) approach avoiding the costs of gene therapies and the adverse effects of antibody therapies. Type: | 0 | 0 | 0 | 14 |
 | Deep Genomics Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology. Type: | 7 | 0 | 1 | 103 |
 | VIB Science meets life. VIB’s core mission is to generate disruptive insights in the molecular underpinning of life and to translate these actively into impactful innovations for patients and society. VIB is an independent research institute where some 1,800 top scientists from Belgium and abroad conduct pioneering basic research. As such, they are pushing the boundaries of what we know about molecular mechanisms and how they rule living organisms such as human beings, animals, plants, and microorganisms. Based on a close partnership with five Flemish universities – Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel, and Hasselt University – … Type: | 14 | 5 | 8 | 1,593 |
 | ProteinQure Peptide-based drug delivery. ProteinQure is a biotech company focused on the design of novel exotic peptides with broad therapeutic applications. Powered by atomic-level simulations and artificial intelligence, we design dynamic peptides that take drugs straight to their target – outperforming other treatment delivery systems. By daring to deliver therapeutics in a novel way we are changing the game for drug development and bringing hope to patients with previously untreatable diseases. At ProteinQure, we pride ourselves on our unique, diverse and cross-disciplinary team that brings together experts from experimental & computational biology, machine learning and software engineering. Type: | 7 | 2 | 2 | 26 |
 | Tell Every Amazing Lady About Ovarian Cancer There is no screening test for ovarian cancer. Learn the signs and symptoms at www.TellEveryAmazingLady.org/facts Tell Every Amazing Lady About Ovarian Cancer Louisa M. McGregor Ovarian Cancer Foundation also known as T.E.A.L.®, was started by Pamela Esposito-Amery and her sister Louisa M. McGregor. T.E.A.L.®'s mission is to promote public awareness and education of the signs, symptoms and risk factors of Ovarian Cancer, while providing support to survivors and raising funds for research in order to find the cure for Ovarian Cancer. View a short video to learn more about who we are and what we do. https://www.youtube.com/watch?v=mmdfQvLucuA Promoting Awareness for … Type: | 5 | 2 | 5 | 11 |
 | Regenerative Medicine Foundation. We are committed to the ethical advancement of an innovative medicine powered by regenerative therapies. Our mission is to accelerate regenerative medicine to improve health and deliver cures. We are committed to the ethical advancement of an innovative medicine powered by regenerative, restorative, and curative technologies. All we do is in service of health, life, and the alleviation of human suffering. The nonprofit Regenerative Medicine Foundation is an influential global network of stakeholders building collaborations across all disciplines and segments of society. Our annual flagship event, the World Stem Cell Summit, is the most inclusive and expansive interdisciplinary, networking, and … Type: | 4 | 0 | 3 | 15 |
 | AMR Industry Alliance The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance. The AMR Industry Alliance brings together over 100 research-based pharmaceutical, generics, biotech and diagnostic companies and associations, to drive and measure the life-sciences’ industry progress to curb #AMR. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Declaration (January 2016) and the Roadmap (September 2016) and measures industry’s progress in the fight against antimicrobial resistance. A first progress report was launched in January 2018, and tracked progress in four different areas (Research and Science, Access, Appropriate Use, and Environment), identify … Type: | 12 | 2 | 7 | 12 |
 | Emily's Entourage Fast Breakthroughs for Cystic Fibrosis Emily's Entourage (EE) is an innovative 501(c)3 foundation that accelerates research for new treatments and a cure for individuals in the final 10% of the cystic fibrosis (CF) community that do not benefit from existing mutation-targeted therapies. CF is a fatal genetic disease primarily affecting the lungs and digestive system. Founded by Emily Kramer-Golinkoff, a woman with advanced stage CF, and her devoted friends and family, the organization has been featured in national media, including the New York Times, STAT, CNN, People, and more. Since 2011, Emily’s Entourage has awarded millions of dollars in research … Type: | 11 | 1 | 10 | 17 |
 | Verona Pharma Developing life enhancing treatments for chronic respiratory diseases Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. If successfully developed and approved, Verona Pharma's product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound. Ensifentrine met the primary endpoint in both ENHANCE-1 and ENHANCE-2 trials demonstrating statistically significant and clinically meaningful improvements in lung function. In addition, ensifentrine significantly reduced the rate of COPD exacerbations in ENHANCE-1 … Type: | 0 | 0 | 0 | 190 |
 | Chemistry Council Of New Jersey Committed to a Better Quality of Life through Science Founded in 1955 by a small group of chemical industry executives who sought to encourage an academic interest in Chemistry, the Chemistry Council of New Jersey (CCNJ), formerly the Chemical Industry Council of New Jersey, has grown in scope and presence to become one of the nation’s leading state trade associations. Advocacy, Government Relations, Trade Association, Association Management, Public Affairs, Professional Development, Chemical, Pharmaceutical, Life Sciences, and Lobbying Type: | 10 | 0 | 9 | 8 |
 | Intégrateurs Industriels du Grand Défi Biomédicaments [Automatic translation follows] support for technological innovation for the production of biomedicines There are 6 of them, the Industrial Integrators of the Grand Défi Biomédicaments have the following missions: - to provide project leaders for the development of technologies for the production of biomedicines (new cellular and a-cellular expression systems, online control, new equipment) with the skills and tools required in the production of antibodies, gene therapy vectors, and cell therapies for the successful completion of their projects, - to provide access to standard bioproduction equipment and an environment conducive to research into the transformation of bioproduction equipment and processes, … Type: | 0 | 0 | 0 | N/A |
 | ANS Biotech Our Services are as Unique as Your Discoveries ANS Biotech, a preclinical CRO dedicated to pain pharmacology, supports drug discovery and development efforts of companies involved in human and animal health, food and nutrition, by providing them with: • Clinically relevant in vivo models for successful R&D of innovative analgesics, especially in the field of inflammatory pain, neuropathic pain and visceral pain ; • Customized scientific studies meeting drug discovery and development objectives ; • Consulting activities. ANS Biotech also offers ALGOGramTM, a unique in vivo screening tool that provides a rapid and cost-effective means to systematically explore pain indications … Type: | 3 | 2 | 1 | 23 |
 | Abcell-bio Human primary cells to enhance your research Specialized in cell culture, Abcell-bio has a 10-year background and experience in Stem Cell Research and Development. Abcell-bio team is composed of experts that can advise you for your research projects. Our technical team is trained to produce high-quality products in the fields of hematopoiesis and vascular biology. We can process several cell types extracted from: * Cord Blood: CD34+ cells, CD133+ cells, CD34- cells, MonoNuclear Cells (MNCs), Endothelial Progenitor Cells (EPCs) * Umbilical Cord (Human Umbilical Vein/Arterial Endothelial Cells (HUVEC, HUAEC) We also created Cell Culture Media to match your needs for … Type: | 1 | 1 | 0 | 9 |
 | YouTechCare [Automatic translation follows] The Digital Ecosystem that combines Consulting, Expertise and Freelancers dedicated to the health industries and technologies YouTechCare: The Solution That Brings Freelancers' Expertise Closer to the Health Industries Faced with the rise of freelancers in the health sector, it is essential to have a platform that connects these highly qualified professionals with the needs of the health industries. It is with this in mind that the YouTechCare solution was created. It aims to bring the expertise of freelancers closer to health industry players, thus offering a suitable response to the growing demand for specialized skills in this … Type: | 5 | 1 | 1 | 2 |
 | Eurofins Optimed Clinical Research A Carte Blanche for the 'Translation' of your 'Pre-Clinical Studies' to 'Early Clinical Trials' Eurofins Optimed’s mission is to contribute to global Health & Safety. With over 30+ years of experience, Eurofins Optimed is a worldwide leader in early clinical trials. Relying on our own ClinPharm Unit and on a strong international network, we provide efficient recruitment of healthy volunteers and patients within Europe. We offer One-Stop clinical trials. According to your needs, Eurofins Optimed can manage all the steps of your trial in Europe including study document design, regulatory requirements, study conduct, monitoring, pharmaceutical operations, bioanalysis, data collection & … Type: | 2 | 2 | 0 | 55 |
 | Sebia France [Automatic translation follows] The world leader in protein separation using innovative electrophoresis systems Sebia France is a subsidiary of the Sebia Group. Founded in 1967, Sebia is a global player specializing in in vitro diagnostics for the screening and monitoring of various diseases, mainly in the fields of oncology (multiple myeloma), diabetes, hemoglobinopathy, autoimmunity and other rare pathologies. Sebia’s mission is to provide powerful tools that translate what is happening in a patient’s body into a readable and interpretable language. We call it our new language of life. Based in the south of Paris (Lisses, France), we have set strict … Type: | 1 | 1 | 0 | 518 |
Startup